However, in colorectal, bladder, and pancreatic cancer, Plk2 was reported as an oncogenic factor because of its overexpression and tumor-promoting effects (Kothari et al. 2013; Ou et al. 2016; Tan et al. 2010). Here, PLK2 is linked to familial pancreatic carcinoma.